Evidence map›Paper›PMID 27628574›Full record

ArticleJournal of the American Heart Association2016

Facility-Level Percutaneous Coronary Intervention Readmission Rates Are Not Associated With Facility-Level Mortality: Insights From the VA Clinical Assessment, Reporting, and Tracking (CART) Program.

Timothy W Hegeman, Thomas J Glorioso, Edward Hess, Anna E Barón, P Michael Ho, Thomas M Maddox, Steven M Bradley, Robert E Burke

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Timothy W HegemanUniversity of Colorado School of Medicine, Aurora, CO Colorado Cardiovascular Outcomes Research Consortium, Denver, CO timothy.hegeman@vanderbilt.edu.
Thomas J GloriosoColorado Cardiovascular Outcomes Research Consortium, Denver, CO VA Eastern Colorado Health Care System, Denver, CO Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
Edward HessColorado Cardiovascular Outcomes Research Consortium, Denver, CO VA Eastern Colorado Health Care System, Denver, CO Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
Anna E BarónUniversity of Colorado School of Medicine, Aurora, CO Colorado Cardiovascular Outcomes Research Consortium, Denver, CO VA Eastern Colorado Health Care System, Denver, CO Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
P Michael HoUniversity of Colorado School of Medicine, Aurora, CO Colorado Cardiovascular Outcomes Research Consortium, Denver, CO VA Eastern Colorado Health Care System, Denver, CO.
Thomas M MaddoxUniversity of Colorado School of Medicine, Aurora, CO Colorado Cardiovascular Outcomes Research Consortium, Denver, CO VA Eastern Colorado Health Care System, Denver, CO.
Steven M BradleyUniversity of Colorado School of Medicine, Aurora, CO Colorado Cardiovascular Outcomes Research Consortium, Denver, CO VA Eastern Colorado Health Care System, Denver, CO.
Robert E BurkeUniversity of Colorado School of Medicine, Aurora, CO VA Eastern Colorado Health Care System, Denver, CO.
University of Colorado Denver · USColorado School of Public Health · USOutcomes Research Consortium · USUniversity of Colorado Anschutz Medical Campus · US

Funding

HSRD VA IK2 HX001796
6 · The paper itself

Abstract

backgroundThirty-day readmission after percutaneous coronary intervention (PCI) is common, costly, and linked to poor patient outcomes. Accordingly, facility-level 30-day readmission rates have been considered as a potential quality measure. However, it is unknown whether facility-level 30-day readmission rates are associated with facility-level mortality. We sought to determine the effect of 30-day readmissions after PCI on mortality at both the patient and facility level in the Veterans Administration hospital system. METHODS AND

resultsWe included all patients who underwent PCI in the Veterans Administration hospital system nationally from October 2007 through August 2012, comparing all-cause mortality rates between patients with and without 30-day readmissions following PCI. Patients were then aggregated at the hospital level to evaluate the correlation between hospital-level readmission rates with hospital-level 1-year mortality rates. Among 41 069 patients undergoing PCI at 62 sites, 12.2% were readmitted within 30 days of discharge. Patients with 30-day readmission had higher risk-adjusted mortality (hazard ratio 1.53, 95% CI 1.44-1.63, P<0.0001). Facilities varied widely in 30-day readmission rates (systemwide range of 6.6-19.4%, median 11.8%, interquartile range 10.0-13.2%); however, adjusted facility-level readmission rates were not correlated with adjusted 1-year mortality rates.

conclusionsThirty-day readmissions after PCI are common and are a significant risk factor for mortality for individual patients even after robust statistical adjustment for clinical confounding. However, lack of correlation between readmission and mortality at the facility level suggests that quality improvement based on facility-level readmission rates will not modify mortality in this high-risk group.

Indexed as

AgedFemaleHumansKaplan-Meier EstimateLength of StayMaleMiddle AgedMyocardial InfarctionPatient ReadmissionPercutaneous Coronary InterventionRetrospective StudiesUnited Statescardiac catheterizationcardiovascular outcomescoronary artery diseasemortalityreadmission

Identifiers

PMID27628574
PMCPMC5079017
OpenAlexW2518824292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.